I am not aware about any SAE’s described to FDA involving this chemical and of course, a single would assume FDA could well be focusing on mislabeled products which Have a very palpable threat to general public safety like say… SARMs?a Combretastatin-A4 (CA-four) could be the common drug to the review. b Values tend to be the indicate ± SD of